Diagenode and MGI Tech (MGI), a subsidiary of global genomics leader BGI Group, today announced a co-marketing agreement for Diagenode’s innovative NGS library preparation product line in the United States, Europe and Asia Pacific.
Under the terms of the non-exclusive agreement, the two companies have made Diagenode’s newest D-Plex Library Preparation products available on the MGI platform. MGI and Diagenode will market and promote Diagenode’s solutions for advanced epigenetic discoveries including the innovative D-Plex small RNA-sequencing technology, specifically formatted to work with MGI’s DNBSEQ™ sequencers using the appropriate MGI-compatible products.
“This agreement brings together our best-in-class and unique library preparation products and MGI’s high-quality cost-effective PCR-free sequencing solution, creating a combined platform to embrace the rapidly expanding markets in USA, Asia Pacific and Europe,” said Didier Allaer, CEO and founder of Diagenode. “This initiative brings premium epigenetics products to MGI’s customers, allowing them to experience exceptional performance and new discoveries.”
Read more
The European Regional Development Fund and Wallonia are investing in your
future.
Extension of industrial buildings and new laboratories.
